Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Healthcare >

Endocan Corp. (ENDO)

ENDO RSS Feed
Add ENDO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sicofbs, bensondog, Doc K
Search This Board:
Last Post: 12/19/2014 10:21:05 AM - Followers: 184 - Board type: Free - Posts Today: 0

About Endocan Corporation

The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.
 

Premium quality of life is one of the most rewarding ways to feel great and outright spoil ourselves. The Endocan product line by The Endocan Corporation is a new stage of
innovative cannabinoid-based solutions, with a fresh focus on the health decisions of today. The critical ailments, such as cancer,AIDS/HIV, asthma, glaucoma, influenza,
pain management, & PTSD to more general conditions, such as sunburn and skin dryness, all seem to have a beneficial response to cannabinoids.
Endocan utilizes the unique and potent benefits of cannabinoids; the natural components found in the cannabis plant.
Cannabinoids are the ideal solution due to their organic properties that the body responds extremely well to. Endogenous endocannabinoid system is responsible for
the unique communication pathways in the brain and body affecting many important functions including modulation of the response to disease. Our formulations
target the endocannabinoid system thus affecting the cause, not only the symptoms. Endocan’s motivation to bring superior products to their respective markets is based on the incredible market need for answers to critical ailments and generalconditions.
The personal care market including   cosmeceuticals, nutraceuticals, and anti-aging is one of the largest in the world.




 

Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.


 

 

 

 

Corporate Overview

"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."

Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.

Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.

Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.

Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.

Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.

Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.

Endocan is poised to flourish in the retailmarket place. Endocan aims to capture a profitable share of the personal care as well as a portion of the critical ailment markets.Endocan diversifies it product base into more product lines and marketing focuses on Endocan becoming more of a household name.
Endocan’s unique formulations matched with Endocan’s unmatched ability to deliver new and exciting products to the market
enhanced by our branding identity is essential to our success. Our formulations include proprietary extracts
that increase the quality, durability, and effectiveness of the products, especially when compared to other consumer options that currently exist on the shelf.
Sales are illustrated to rise to over $100million dollars over five to ten years as the
company benefits from both global expansion and franchising opportunities.


 

                        

           About Cannabis & Cannabinoids

About CannabiinoidsThere are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”

Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:

 

  • Cannabigerols (CBG)
  • Cannabichromenes (CBC)
  • Cannabidiols (CBD)
  • Tetrahydrocannabinols (THC)
  • Cannabinol (CBN) and Cannabinodial (CBDL)
  • Other Cannabinoids

The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”


 

The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.


 

A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.


History of Cannabis

The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.

In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.

The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.

 

     

      

 

Critical Ailments

Endocan develops products for critical ailments.

The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.

Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.

Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:

Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?

Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.


 

Table: Market Analysis


 



Market Analysis Chart


 

Table: Global Potential Customers

Global Potential Customers Chart



Table: Global Potential Customers - Cancer

Global Potential Customers with Cancer Chart



 

     

 


                                                                                        

Corporate Profile

Endocan is dedicated to quality, respect for human life, and constant evaluation.

Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.

Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.

 

Executive Summary

Please click on the document title to download.

Download PDF Document Endocan Corporation 2013 Executive Summary


Endocan Moves Forward With New Product Releases After Successful Brand and Website Launch; Focused Efforts Include Product Distribution Outlets for USA, Canada, and Europe Oct-23-2013
Endocan Corporation (XCHC) is Pleased to Announce the Endocan™ www.endocan.com Website Goes Live Today Oct-17-2013
Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan™ on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding to Bring its Medical Cannabis Formulations to Market as its Next Major Corporate Move Oct-14-2013
Endocan Corporation, FKA The X-Change Corp, Motivated by Canadian Government Move; From Huffington Post: 'Canada Medical Marijuana: Health Canada Presides Over Birth Of Billion-Dollar Free Market' Oct-01-2013
XCHC Changes Corporate Name to "Endocan Corporation"; Medical Cannabis Industry-Driven Branding Campaign Begins with Name Change and Continues into the Arizona Dispensary Opening Sep-26-2013
The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website Sep-06-2013
X-Change Corp. Recaps Significant Corporate Activities for Past 15 Days Sep-05-2013
X-Change Corp. Delighted with DOJ's Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees 'Green Light' for Company's Patient-Driven Medical Cannabis Operations Under State Laws Aug-30-2013
X-Change Moves Forward Signing Next Multi-Year Contracts with State-Licensed Medical Cannabis Dispensary in Arizona to Develop, Dispense, Infuse, and Cultivate Products for On-Site, Use of 'Medbox' Technology for Fulfillment, and Distribution Aug-21-2013
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting Aug-20-2013





Management Team
 

Dr Dorothy Bray, Ph.D.
Director & President
 
Chad S. Johnson, Esq.
Director, COO &General Counsel
 
Mario Lap
Director & President of European Operations
 
Robert Kane
Director, CFO & Sr.VP for Business Development
 
Alfredo Dupetit
Director & VP European Operations
 
Drue Young
Vice President of Product Development

 
Steven B. Hopping, M.D., F.A.C.S.

 
Board of Advisors, Senior Medical Advisor
Greta Gaines

 
Board of Advisors, Marketing Specialist
Greta Gaines

_______________________________________________________________________________________________________________



Company Stock Symbol
XCHC - View Stock Quote


Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001

Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001

Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120
Email: signaturestock@aol.com

http://www.endocan.com/


 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENDO
Current Price
Volume:
Bid Ask Day's Range
Wiki
ENDO News: Amended Current Report Filing (8-k/a) 07/10/2014 05:03:09 PM
PostSubject
#8448   Dabney ran his first Cbis product story sicofbs 12/19/14 10:21:05 AM
#8447   I think Dabney should photo himself in front sicofbs 12/18/14 11:16:44 AM
#8446   There are so many issues with this and sicofbs 12/17/14 11:13:42 AM
#8442   Coincidentally, today, I thought the same whether this Heinekenken 12/09/14 01:12:33 PM
#8441   If this gets halted the house of cards sicofbs 12/09/14 11:15:14 AM
#8440   They haven't haulted this pos yet? Doc K 12/09/14 10:39:16 AM
#8439   I'm guessing the products Dabney says he has sicofbs 12/08/14 07:21:50 PM
#8436   Have faith...I'm sure they are ready to announce sicofbs 11/27/14 12:57:08 PM
#8434   END and OVER Not gonna happen, that's Heinekenken 11/26/14 04:24:45 PM
#8433   Not looking to good for endo or Cbis sicofbs 11/24/14 10:11:22 AM
#8432   I hope they are turning....pretty ridiculous year considering sicofbs 11/23/14 04:09:45 PM
#8431   I'm just sitting here watching the wheels go Vmax1 11/21/14 02:17:22 PM
#8430   DAMIT KANE! WHERE IS THAT GOSH DANG Doc K 11/20/14 08:45:59 PM
#8429   Yeah, we never know cause not gonna happen Heinekenken 11/16/14 10:09:41 PM
#8427   Gosh,it is a year already since Kane announced sicofbs 11/11/14 03:39:04 PM
#8426   Thei apparent scam launched by Kane is all sicofbs 11/08/14 01:46:01 PM
#8425   Did Dabney appoint himself CEO here also? Doc K 11/07/14 05:01:58 PM
#8424   I kinda know.....this is the gate the FBI sicofbs 11/07/14 09:10:15 AM
#8422   Never know tho. bensondog 11/05/14 01:29:58 AM
#8421   Read it, sounds good. bensondog 11/05/14 01:29:02 AM
#8420   Maybe more states legalizing? bensondog 11/05/14 01:28:11 AM
#8419   Seems to be going up this last week. bensondog 11/05/14 01:27:36 AM
#8418   It appears Dorothy was being a Dabney last sicofbs 11/04/14 11:42:18 AM
#8417   Last 10Q 3/2013 on ENDO awaiting an SEC bitch-slap. PressureWasherGuy 11/04/14 10:03:22 AM
#8416   Just find it strange. Stagnant, no signs of Veets307 11/03/14 04:09:01 PM
#8415   Prob an inside job to pump the tires jfboston 11/03/14 04:03:25 PM
#8414   I've been following endo stagnant at 0.2 - Veets307 11/03/14 02:38:41 PM
#8413   Marijuana lol StockWizard 11/03/14 02:28:16 PM
#8412   Why is this rising? Based on what? Veets307 11/03/14 02:20:09 PM
#8411   This has to do with kmberly mueller. Anyone VS1 11/03/14 11:24:42 AM
#8410   Rising KnowBuddy 11/03/14 10:27:36 AM
#8409   Hey bray...what's the deal....first you renamed the company sicofbs 11/01/14 05:27:51 PM
#8408   Hey Kane I see your a big shot sicofbs 10/29/14 09:50:21 AM
#8407   This symbol will result in Robert Kane going sicofbs 10/28/14 01:48:16 PM
#8406   Re rules in Canada, i want you to Veets307 10/27/14 02:13:44 PM
#8405   are the rules less strict in Canada with dazetrader 10/27/14 10:38:17 AM
#8404   ENDO; a failure YTD. PressureWasherGuy 10/27/14 09:20:01 AM
#8403   http://www.phytiva.com/press-releases/116-xchc-signs-historic-agreement-with-wol Doc K 10/22/14 11:31:57 PM
#8401   Phytiva, oh Phytiva. Where art thou oh Doc K 10/22/14 11:14:05 PM
#8400   Love these old news releases ... What a sicofbs 10/20/14 04:39:38 PM
#8399   Great news !!!!! About time Kane http://ih.advfn.com/p.php?pid=nmona&article=560 sicofbs 10/19/14 09:59:41 PM
#8397   LLY MDBX CBIS ENDO NEWC IMCL CBCA -any more?? VS1 10/15/14 01:07:17 PM
#8396   Your forget about about NEWC ? Doing great. VS1 10/15/14 11:04:46 AM
#8395   Not at all ....things went good ...they came Vmax1 10/14/14 07:44:27 PM
#8394   Ebola pr.... Ok... I'd not bet on that sicofbs 10/14/14 03:58:43 PM
#8393   I guess the Starmen didn't want to be Doc K 10/14/14 03:17:51 PM
#8392   Still around :). FA is happening Vmax1 10/14/14 02:30:52 AM
#8391   That was Vmax1 ...he was a nice guy...he sicofbs 10/13/14 01:42:27 PM
#8390   If they actually proved to shareholders who seemingly sicofbs 10/12/14 01:21:58 PM
#8389   A short review.. sicofbs 10/10/14 11:56:56 AM
PostSubject